Schizophrenia - Current Treatment - Detailed, Expanded Analysis (EU5)
Current Treatment Schizophrenia EU5 August 2023
Riya Kanakhara, B.Tech.,Associate Healthcare Research & Data Analyst, CNS and Ophthalmology. Ms. Kanakhara has substantial experience in market research and has produced competitive intelligence reports in multiple therapy areas, including oncology, ophthalmology, neurology, and psychiatry. She has also prepared post-conference reports for conferences such as the American Academy of Neurology. She holds a bachelor’s degree in biotechnology from Amity University in India.
Himanshu Jain, M.S. Pharm.
Himanshu Jain, M.S.(Pharm.), Senior Manager, CNS and Ophthalmology. He has authored content for psychiatry and ophthalmology indications, including forecasting markets for schizophrenia, depression, and dry eye disease. He has about 15 years of experience working in market research and consulting firms. He earned his master’s degree in Pharmacology & Toxicology from the National Institute of Pharmaceutical Education and Research and holds an Executive Post-Graduate Diploma in International Business from the Indian Institute of Foreign Trade.